Inhalation Sciences Sweden: announces Redeye to begin regular monitoring of stock analysis of the company
(Stockholm, Sweden, September 29, 2021) Inhalation Sciences AB (ISAB) announces Today, it has commissioned Redeye to regularly, in-depth stock analysis of the company. The strategic goal is to increase ISAB’s market profile and visibility, so that investors and stakeholders can develop a better understanding of the business and its results and future prospects. Redeye specializes […]